Literature DB >> 17157418

Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.

P L Eblé1, A Bouma, K Weerdmeester, J A Stegeman, A Dekker.   

Abstract

The aim of this study was to determine a possible correlation between humoral immune responses shortly after vaccination and protection against foot-and-mouth disease virus (FMDV) infection and to study the serological and mucosal antibody responses after vaccination and infection. We used three groups of ten pigs, one non-vaccinated group, one group vaccinated with a single dose vaccine and one group vaccinated with a four-fold dose vaccine. At 7 days post vaccination, five pigs per group were challenged intra-dermally with FMDV O TAW 3/97 and the remaining pigs of each group were contact-exposed to the inoculated pigs. In each group, virus excretion and number of contact infections were quantified. The serological and mucosal antibody responses were evaluated until 116 days post infection. Vaccination resulted in a significant decrease of virus excretion. Stepwise linear regression analysis of variables from individual vaccinated pigs revealed the virus excretion after challenge to be correlated with neutralising antibody titres at the day of challenge (p<0.01). In serum and OPF samples comparable isotype-specific antibody responses (IgM, IgG and IgA), could be detected after vaccination as well as after infection. Remarkably, the pigs with the highest IgA responses after vaccination were protected against contact exposure. After infection, a long lasting (up to 116dpi) IgA response was seen in the non-vaccinated and to a lesser extent in the single dose vaccinated pigs. The induction of NSP antibodies in the vaccinated pigs after infection was lower and of shorter duration as compared to the non-vaccinated infected pigs. This experiment shows that vaccination can reduce virus excretion in pigs, which will contribute to reduced transmission of FMDV in the field, even if the pigs are not fully protected. Moreover, vaccines that induce local IgA responses may be more effective, which merits further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157418     DOI: 10.1016/j.vaccine.2006.09.066

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine.

Authors:  Miguel Rodríguez Pulido; Francisco Sobrino; Belén Borrego; Margarita Sáiz
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

2.  New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.

Authors:  Teresa Rodríguez-Calvo; Samuel Ojosnegros; Marta Sanz-Ramos; Juan García-Arriaza; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

3.  Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide.

Authors:  Carolina Cubillos; Beatriz G de la Torre; Annamaria Jakab; Giorgia Clementi; Eva Borrás; Juan Bárcena; David Andreu; Francisco Sobrino; Esther Blanco
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

4.  Immune response and viral persistence in Indian buffaloes (Bubalus bubalis) infected with foot-and-mouth disease virus serotype Asia 1.

Authors:  Mohan S Maddur; Subodh Kishore; S Gopalakrishna; Nem Singh; V V Suryanarayana; Mukund R Gajendragad
Journal:  Clin Vaccine Immunol       Date:  2009-10-14

5.  IgA antibody response of swine to foot-and-mouth disease virus infection and vaccination.

Authors:  Juan M Pacheco; John E Butler; Jessica Jew; Geoffrey S Ferman; James Zhu; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

6.  Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.

Authors:  Carolina Cubillos; Beatriz G de la Torre; Juan Bárcena; David Andreu; Francisco Sobrino; Esther Blanco
Journal:  Virol J       Date:  2012-03-14       Impact factor: 4.099

7.  B epitope multiplicity and B/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines.

Authors:  Esther Blanco; Carolina Cubillos; Noelia Moreno; Juan Bárcena; Beatriz G de la Torre; David Andreu; Francisco Sobrino
Journal:  Clin Dev Immunol       Date:  2013-12-03

8.  Systemic immune response and virus persistence after foot-and-mouth disease virus infection of naïve cattle and cattle vaccinated with a homologous adenovirus-vectored vaccine.

Authors:  Michael Eschbaumer; Carolina Stenfeldt; Steven I Rekant; Juan M Pacheco; Ethan J Hartwig; George R Smoliga; Mary A Kenney; William T Golde; Luis L Rodriguez; Jonathan Arzt
Journal:  BMC Vet Res       Date:  2016-09-15       Impact factor: 2.741

Review 9.  Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review.

Authors:  Sarah J Cox; Paul V Barnett
Journal:  Vet Res       Date:  2008-12-02       Impact factor: 3.683

Review 10.  Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity.

Authors:  Mohammed Habiela; Julian Seago; Eva Perez-Martin; Ryan Waters; Miriam Windsor; Francisco J Salguero; James Wood; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2014-07-07       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.